The use of the corticosteroid methylprednisolone, as compared to placebo, decreased treatment failure among patients with severe community-acquired pneumonia and high initial inflammatory response. Despite advances in antibiotic treatment, community-acquired pneumonia is the leading infectious cause of death in developed countries. Treatment failure is associated with excessive inflammatory response and worse outcomes in the patients. Researchers randomly ...
No comments:
Post a Comment